Press Release: Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with deepening improvements in post-swallow residue and total dysphagic symptom burden as compared to the 12-month follow-up timepoint
TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sustainable Innovation & Health Dividend Fund (TSX: SIH.UN) (the “Fund”) is pleased to announce that distributions for the first quarter of 2026 will be payable to unitholders of Sustainable Innovation & Health Dividend Fund as follows:
SANTA CLARA, CA, Jan. 23, 2026 (GLOBE NEWSWIRE) -- SANTA CLARA, CA - January 23, 2026 - - As artificial intelligence automates more aspects of software development, a counterintuitive shift is reshaping how engineers are evaluated and hired: fundamental computer science skills are becoming more important, not less. Leading technology companies and hiring managers now…
FRANKFURT, Germany, Jan. 23, 2026 (GLOBE NEWSWIRE) -- KraneShares, a global asset manager known for its innovative exchange-traded funds (ETFs), announced the cross-listing of the KraneShares Global Humanoid & Embodied Intelligence Index UCITS ETF on Deutsche Börse Xetra, where it will trade under the ticker KBOT.
COLUMBIA, Mo., Jan. 22, 2026 (GLOBE NEWSWIRE) -- EquipmentShare.com Inc (“EquipmentShare”), a leader in connected jobsite technology and one of the largest equipment rental providers in the United States, today announced that it priced its initial public offering of 30,500,000 shares of its Class A common stock (the “Offering”), par value $0.00000125 per share, at…
WINTER PARK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets and commodity-backed stablecoins, including GLDY, today announced the pricing of its previously announced underwritten public offering of 11,666,667 shares of common stock at a public offering price of $3.00 per…
